American Vietnamese Biotech Incorporation (HNX:AMV)

Vietnam · Delayed Price · Currency is VND

1,200.00

-100.00 (-7.69%)

At close: Aug 12, 2026

HNX:AMV Financials Overview

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	102,406	159,667	310,355	196,570	281,818	223,843
Revenue Growth	-69.04%	-48.55%	57.88%	-30.25%	25.90%	38.66%
Gross Profit	12,211	21,844	31,261	49,592	78,949	113,694
Operating Income	-29,637	-44,043	-4,313	32,471	63,472	99,666
Net Income	-71,166	-72,637	-11,191	10,685	53,931	82,240
Earnings Per Share	-543.03	-554.04	-85.36	81.00	502.00	977.00
EPS Growth	-	-	-	-83.86%	-48.62%	-33.47%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	8,807	62,371	17,274	84,185	77,996	29,030
Total Debt	160,626	149,626	154,625	166,763	170,519	182,483
Net Cash (Debt)	-151,819	-87,255	-137,351	-82,577	-92,523	-153,453
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1158.45	-665.53	-1047.64	-629.85	-861.21	-1823.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	57,077	388,673	674,905	-137,858	-346,202	-437,435
Capital Expenditures	-16,328	-16,328	-46,375	-6,934	-1,485	-73,459
Free Cash Flow	40,749	372,344	628,530	-144,792	-347,688	-510,894
Free Cash Flow Growth	-95.34%	-40.76%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	11.92%	13.68%	10.07%	25.23%	28.01%	50.79%
Operating Margin	-28.94%	-27.58%	-1.39%	16.52%	22.52%	44.52%
Pretax Margin	-69.63%	-46.16%	-3.70%	5.83%	20.04%	36.46%
Profit Margin	-69.49%	-45.49%	-3.61%	5.44%	19.14%	36.74%
FCF Margin	39.79%	233.20%	202.52%	-73.66%	-123.37%	-228.24%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	47.85	8.02	15.95
P/FCF Ratio	3.86	0.70	0.31	-	-	-
PS Ratio	1.54	1.64	0.63	2.60	1.54	5.86